+44-330-822-4832
+44-330-822-4832Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Dr. Kurosu has a long-term interest in development of new antibacterial agents targeting novel or unexploited drug targets. In order to develop novel antibacterial molecules, he develops concise syntheses of relatively complex molecules, and designs chiral molecules and generates small optimized libraries. He also develops convenient assays against target enzymes of interest. These efforts have resulted in the discovery of several new drug leads effective against MDR-Gram-positive pathogens including MDR-M. tuberculosis. Over the last 10 years, he has studied electron transport system, menaquinone biosynthesis, unexploited peptidoglycan biosynthesis, and bacterial kinases.
Synthesis and Biological Evaluation of Biologically Active Natural Products, Rational drug design, bioorganic chemistry, Development of Enzymatic Assays of Small Molecules, and New Chemical Tools.
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 
